Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![$ucbjf Graphic](https://lunarcrush.com/gi/w:26/t:$ucbjf.png) $ucbjf

$ucbjf sees positive sentiment amidst market volatility. Recent posts highlight developments in related assets like $STOK and $DRUG, driving engagement and discussion.

### About $ucbjf
A cryptocurrency.  

### Engagements: XXX [#](/topic/$ucbjf/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$ucbjf/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$ucbjf/time-series/interactions.tsv)  
**Current Value**: XXX  
**Daily Average**: XXX  
**1 Week**: XXX -XX%  
**1 Month**: XXX -XX%  
**1-Year High**: XXXXX on 2025-07-10  
**1-Year Low**: X on 2025-05-08  

| Social Network | X   |
| -------------- | -   |
| Engagements    | XXX |
  

  
  
### Mentions: X [#](/topic/$ucbjf/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$ucbjf/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$ucbjf/time-series/posts_active.tsv)  
**Current Value**: X  
**Daily Average**: X  
**1 Week**: X no change  
**1 Month**: X -XX%  
**1-Year High**: X on 2025-08-03  
**1-Year Low**: X on 2025-04-28  

| Social Network | X |
| -------------- | - |
| Mentions       | X |
  

  
  
### Creators: X [#](/topic/$ucbjf/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$ucbjf/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$ucbjf/time-series/contributors_active.tsv)  
X unique social accounts have posts mentioning $ucbjf in the last XX hours which is no change from in the previous XX hours
**Daily Average**: X  
**1 Week**: X no change  
**1 Month**: X -XX%  
**1-Year High**: X on 2025-08-03  
**1-Year Low**: X on 2025-04-28  

The most influential creators that mention $ucbjf in the last XX hours

| Creator                                    | Rank | Followers | Posts | Engagements |
| -------                                    | ---- | --------- | ----- | ----------- |
| [@Quantumup1](/creator/twitter/Quantumup1) | X    | XXXXX     | X     | XXX         |

[View More](/list/creators/$ucbjf/100)

**Top assets mentioned**
In the posts about $ucbjf in the last XX hours

[Acadia Pharmaceuticals Inc. (ACAD)](/topic/$acad)
[Biogen Inc (BIIB)](/topic/biogen-inc)
[Jazz Pharmaceuticals, Inc. (JAZZ)](/topic/$jazz)

**Top topics mentioned**
In the posts about $ucbjf in the last XX hours

[$acad](/topic/$acad), [biogen inc](/topic/biogen-inc), [$stoks](/topic/$stoks), [$ucbjy](/topic/$ucbjy), [$stok](/topic/$stok), [$jazz](/topic/$jazz), [stocks healthcare](/topic/stocks-healthcare)

### Top Social Posts [#](/topic/$ucbjf/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"Needhamthe PT on $STOK to $XX from $XX and reiterated at a Buy rating after STOK presented new zorevuneren OLE data in Dravet Syndrome (DS) at the 54th Child Neurology Society (CNS) annual meeting yesterday. $BIIB $JAZZ UCBJY UCBJF Needham said in its note: The new data showed 1) patients treated with zorevunersen had continued improvements in clinical outcomes through X years and 2) an analysis of patients in the OLE who received a similar dosing regimen as the ongoing Ph3 trial continued to show improvements in the Vineland-3 (cognition & behavior) at X years vs. a DS natural history study."  
[X Link](https://x.com/Quantumup1/status/1976615201718903033) [@Quantumup1](/creator/x/Quantumup1) 2025-10-10T11:46Z 3846 followers, 1793 engagements


"BTIG $STOK's PT to $XX from $XX reiterated at a Buy and said that the 36-month data for Zorevunersen (STK-001) seems to bury any remaining questions. $UCBJY $UCBJF $JAZZ $BIIB $ACAD $DNLI BTIG said in its note:"  
[X Link](https://x.com/Quantumup1/status/1957523671742050745) [@Quantumup1](/creator/x/Quantumup1) 2025-08-18T19:23Z 3846 followers, 4067 engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$ucbjf Graphic $ucbjf

$ucbjf sees positive sentiment amidst market volatility. Recent posts highlight developments in related assets like $STOK and $DRUG, driving engagement and discussion.

About $ucbjf

A cryptocurrency.

Engagements: XXX #


Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXX
1 Week: XXX -XX%
1 Month: XXX -XX%
1-Year High: XXXXX on 2025-07-10
1-Year Low: X on 2025-05-08

Social Network X
Engagements XXX

Mentions: X #


Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: X
1 Week: X no change
1 Month: X -XX%
1-Year High: X on 2025-08-03
1-Year Low: X on 2025-04-28

Social Network X
Mentions X

Creators: X #


Creators Line Chart
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning $ucbjf in the last XX hours which is no change from in the previous XX hours Daily Average: X
1 Week: X no change
1 Month: X -XX%
1-Year High: X on 2025-08-03
1-Year Low: X on 2025-04-28

The most influential creators that mention $ucbjf in the last XX hours

Creator Rank Followers Posts Engagements
@Quantumup1 X XXXXX X XXX

View More

Top assets mentioned In the posts about $ucbjf in the last XX hours

Acadia Pharmaceuticals Inc. (ACAD) Biogen Inc (BIIB) Jazz Pharmaceuticals, Inc. (JAZZ)

Top topics mentioned In the posts about $ucbjf in the last XX hours

$acad, biogen inc, $stoks, $ucbjy, $stok, $jazz, stocks healthcare

Top Social Posts #


Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"Needhamthe PT on $STOK to $XX from $XX and reiterated at a Buy rating after STOK presented new zorevuneren OLE data in Dravet Syndrome (DS) at the 54th Child Neurology Society (CNS) annual meeting yesterday. $BIIB $JAZZ UCBJY UCBJF Needham said in its note: The new data showed 1) patients treated with zorevunersen had continued improvements in clinical outcomes through X years and 2) an analysis of patients in the OLE who received a similar dosing regimen as the ongoing Ph3 trial continued to show improvements in the Vineland-3 (cognition & behavior) at X years vs. a DS natural history study."
X Link @Quantumup1 2025-10-10T11:46Z 3846 followers, 1793 engagements

"BTIG $STOK's PT to $XX from $XX reiterated at a Buy and said that the 36-month data for Zorevunersen (STK-001) seems to bury any remaining questions. $UCBJY $UCBJF $JAZZ $BIIB $ACAD $DNLI BTIG said in its note:"
X Link @Quantumup1 2025-08-18T19:23Z 3846 followers, 4067 engagements

$ucbjf
/topic/$ucbjf